









Markets
/
Stocks
/
nasdaq-hims
/

Hims & Hers Health Inc

HIMS

27.090USD

-2.780-9.31%

Close 01/30, 16:00（ET）Quotes delayed by 15 min

6.16BMarket Cap

45.24P/E TTM



Hims & Hers Health Inc

27.090

-2.780-9.31%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Hims & Hers Health Inc

Currency: USD Updated: 2026-01-30

Key Insights

Hims & Hers Health Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 39 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 42.59.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hims & Hers Health Inc's Score

Industry at a Glance

Industry Ranking

39 / 75

Overall Ranking

174 / 4536

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive+

Hims & Hers Health Inc Highlights

StrengthsRisks

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 180.22% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is 45.24, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 207.42M shares, decreasing 3.81% quarter-over-quarter.

Held by Paul Tudor Jones

Star Investor Paul Tudor Jones holds 387.49K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.72.

Analyst Rating

Based on 16 analysts

Hold

Current Rating

42.594

Target Price

+42.60%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-30

The current financial score of Hims & Hers Health Inc is 8.92, ranking 14 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 598.98M, representing a year-over-year increase of 49.16%, while its net profit experienced a year-over-year increase of 79.13%.

Score

Industry at a Glance

Previous score

8.92

Change



Financials

7.06

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.86

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.68

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Hims & Hers Health Inc's Company Valuation

Currency: USD Updated: 2026-01-30

The current valuation score of Hims & Hers Health Inc is 5.71, ranking 68 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 45.24, which is 507.93% below the recent high of 275.02 and 4767.70% above the recent low of -2111.58.

Score

Industry at a Glance

Previous score

5.71

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 39/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-30

The current earnings forecast score of Hims & Hers Health Inc is 6.13, ranking 60 out of 75 in the Healthcare Providers & Services industry. The average price target is 41.00, with a high of 85.00 and a low of 30.00.

Score

Industry at a Glance

Previous score

6.13

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts

Hold

Current Rating

42.594

Target Price

+42.60%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hims & Hers Health Inc

HIMS

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-30

The current price momentum score of Hims & Hers Health Inc is 6.72, ranking 50 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 33.40 and the support level at 23.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.08

Change

-0.36

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.240

Sell

RSI(14)

31.993

Neutral

STOCH(KDJ)(9,3,3)

22.069

Sell

ATR(14)

1.831

Low Volatility

CCI(14)

-156.496

Sell

Williams %R

96.563

Oversold

TRIX(12,20)

-0.780

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

29.118

Sell

MA10

29.647

Sell

MA20

31.408

Sell

MA50

34.407

Sell

MA100

42.376

Sell

MA200

45.845

Sell

Institutional Confidence

Currency: USD Updated: 2026-01-30

The current institutional shareholding score of Hims & Hers Health Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 94.59%, representing a quarter-over-quarter increase of 6.15%. The largest institutional shareholder is The Vanguard, holding a total of 20.88M shares, representing 9.52% of shares outstanding, with 11.26% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

22.09M

+1.91%

The Vanguard Group, Inc.

Star Investors

19.47M

+4.51%

Capital World Investors

18.78M

+1.21%

JP Morgan Asset Management

12.87M

+2026.69%

Farallon Capital Management, L.L.C.

10.75M

+30.84%

Dudum (Andrew)

9.50M

+0.78%

Renaissance Technologies LLC

Star Investors

9.10M

+32.42%

Goldman Sachs & Company, Inc.

8.54M

+13.24%

State Street Investment Management (US)

7.17M

+1.88%

Morgan Stanley & Co. LLC

5.93M

+46.43%

Risk Assessment

Currency: USD Updated: 2026-01-30

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Hims & Hers Health Inc is 4.46, ranking 50 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 2.43. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.